NCT04741477View on ClinicalTrials.gov

The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

July 14, 2021

Primary Completion Date

September 16, 2022

Study Completion Date

September 16, 2022

Conditions
CannabisDrug Effect
Interventions
DRUG

CBD

CBD will be topically applied

DRUG

THC

THC will be topically applied

DRUG

Placebo

a placebo product (without cannabinoids) will be topically applied

Trial Locations (1)

21224

Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore

All Listed Sponsors
collaborator

Substance Abuse and Mental Health Services Administration (SAMHSA)

FED

lead

Johns Hopkins University

OTHER